S
0.384
0.01 (3.33%)
| Previous Close | 0.372 |
| Open | 0.392 |
| Volume | 253,026 |
| Avg. Volume (3M) | 1,271,615 |
| Market Cap | 15,618,486 |
| Price / Earnings (TTM) | 0.513 |
| Price / Earnings (Forward) | 21.83 |
| Price / Sales | 8.30 |
| Price / Book | 0.210 |
| 52 Weeks Range | |
| Earnings Date | 7 Aug 2025 - 11 Aug 2025 |
| Operating Margin (TTM) | -34,814.94% |
| Diluted EPS (TTM) | 0.660 |
| Quarterly Revenue Growth (YOY) | -58.70% |
| Total Debt/Equity (MRQ) | 4.70% |
| Current Ratio (MRQ) | 1.05 |
| Operating Cash Flow (TTM) | -7.03 M |
| Levered Free Cash Flow (TTM) | -6.06 M |
| Return on Assets (TTM) | -14.99% |
| Return on Equity (TTM) | -35.92% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Pharmaceutical Retailers (US) | Mixed | Mixed |
| Pharmaceutical Retailers (Global) | Mixed | Bullish | |
| Stock | Scienture Holdings, Inc. | - | - |
AIStockmoo Score
0.8
| Analyst Consensus | 0.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 0.75 |
|
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S. |
|
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Investment Style | Small Core |
| % Held by Insiders | 32.59% |
| % Held by Institutions | 1.35% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Nova Wealth Management, Inc. | 31 Dec 2025 | 30 |
| 52 Weeks Range | ||
| Median | 1.50 (290.22%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Maxim Group | 24 Feb 2026 | 1.50 (290.22%) | Buy | 0.384 |
No data within this time range.
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 19 Jul 2024 | 08 Jul 2024 | 24 Jul 2024 | 1.5 Cash |
| 25 Mar 2024 | 28 Feb 2024 | 22 Mar 2024 | 8 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 9.50 | 2 | 157.03 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |